Clinical Trial Update: Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic Syndrome. [Phase 3]

View source ↗

Summary

This document provides a status update on a Phase 3 clinical trial evaluating the effectiveness and safety of Luspatercept in patients with lower-risk myelodysp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Luspatercept (luspatercept)

Snippet

Sponsor: GWT-TUD GmbH | Conditions: Myelodysplastic Syndromes | Phase 3 | Status: ACTIVE_NOT_RECRUITING